Your session is about to expire
← Back to Search
START Program for Opioid Addiction (START Trial)
START Trial Summary
This trial is testing whether a collaborative care team can increase the use of two interventions - medication for opioid use disorder and discharge planning for those with opioid use disorder - and improve linkage to follow-up care.
START Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSTART Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.START Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am currently admitted as an inpatient at CSMC, UNM, or BH.My primary language is either English or Spanish.I am currently on FDA-approved medication for opioid addiction.I am 18 years old or older.I am willing and able to participate in follow-up calls and provide my contact information.
- Group 1: Substance Use Treatment and Recovery Team (START)
- Group 2: Usual Care
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is the recruitment process currently open for participants in this research?
"Correct. The information present on clinicaltrials.gov attests that this trial, which was initially posted on November 11th 2021, is currently recruiting for 414 individuals from 3 distinct medical centres."
How many participants are there in the current clinical trial?
"A total of 414 qualified individuals must join this medical trial. Patricipants can enlist from the University of New mexico Hospital in Albuquerque, NM or Baystate Medical Center located in Springfield, MA."
What are the primary goals this clinical experiment seeks to accomplish?
"This 30-day clinical trial will primarily measure the rate of MOUD therapy initiation in hospital. Secondary objectives focus on OUD-specific discharge plans, post-discharge MOUD use and outpatients medical care within a month after leaving the hospital."
Share this study with friends
Copy Link
Messenger